Moderna Covid booster targeting Omicron variant approved by Therapeutic Goods Administration

Australia's Therapeutic Goods Administration has given provisional approval to Moderna's bivalent Covid vaccine designed to target both the Omicron variant of the virus and the original Covid strain.